The Stanford Stroke Center, one of the first comprehensive multidisciplinary centers of its kind, was established in 1992 to develop new approaches to diagnose and treat stroke. The mission of the Stroke Center is to be the best comprehensive organization in the United States focused on stroke diagnosis, treatment, research, and education. In 1992 the Center was established by a team of neurologists, neurosurgeons, neuroradiologists, nurse specialists, basic scientists, and clinical researchers. This multi- disciplinary team has met regularly to continually refine the program for over 20 years. In 2012, the Joint Commission and the American Heart Association/American Stroke Association announced that the Stanford Stroke Center was the first hospital in the United States to meet The Joint Commission's standards for Disease-Specific Care Comprehensive Stroke Center Certification. In conjunction with Stanford's highly successful neurological emergency treatment trials network (NETT), the Stanford-RCC will provide high volume enrollment of diverse patient populations into NINDS funded stroke trials. The Stanford-RCC will also offer an innovative multidisciplinary fellowship program that will provide comprehensive training in clinical trial design, implementation and analysis. In addition, Stanford faculty members will propose new clinical trials for implementation through the new NINDS Stroke Network.

Public Health Relevance

The Stanford Stroke Center will develop a comprehensive stroke network consisting of 10 clinical trial sites that will provide a high volume of patient enrollment into NINDS funded stroke trials. The network will create a fellowship program that will provide comprehensive training in clinical trial design, implementation and analysis. In addition, Stanford faculty members will propose new clinical trials for implementation through the new NINDS Stroke Network.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10NS086487-03
Application #
8895434
Study Section
Special Emphasis Panel (ZNS1-SRB-G (68))
Program Officer
Vivalda, Joanna
Project Start
2013-09-30
Project End
2018-07-31
Budget Start
2015-08-01
Budget End
2016-07-31
Support Year
3
Fiscal Year
2015
Total Cost
$291,345
Indirect Cost
$150,155
Name
Stanford University
Department
Neurology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Albers, Gregory W (2018) Late Window Paradox. Stroke 49:768-771
Albers, Gregory W; Marks, Michael P; Kemp, Stephanie et al. (2018) Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med 378:708-718
Marks, Michael P; Heit, Jeremy J; Lansberg, Maarten G et al. (2018) Endovascular Treatment in the DEFUSE 3 Study. Stroke 49:2000-2003
Albers, Gregory W; Lansberg, Maarten G; Kemp, Stephanie et al. (2017) A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke 12:896-905
Kasasbeh, Aimen S; Christensen, Søren; Straka, Matus et al. (2016) Optimal Computed Tomographic Perfusion Scan Duration for Assessment of Acute Stroke Lesion Volumes. Stroke 47:2966-2971
Lansberg, Maarten G; Bhat, Ninad S; Yeatts, Sharon D et al. (2016) Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III Data. Stroke 47:2931-2937
Liebeskind, David S; Albers, Gregory W; Crawford, Karen et al. (2015) Imaging in StrokeNet: Realizing the Potential of Big Data. Stroke 46:2000-6